Atlas Trials

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

Clinical trial NCT03604406 · COMPLETED

Trial details

NCT number
NCT03604406
Sponsor
Kevin Winthrop
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes ZosterInflammatory DiseaseRheumatoid Arthritis
Start date
2014-05-08
Primary completion
2024-06-30
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.